- Advanced search
- Immuno Portal
- Malaria Portal
mosapride is an approved drug
Compound class: Synthetic organic
Comment: Marketed formulations contain mosapride citrate (PubChem CID 119583).
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Bender E, Pindon A, van Oers I, Zhang YB, Gommeren W, Verhasselt P, Jurzak M, Leysen J, Luyten W. (2000)
Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant.
J Neurochem, 74 (2): 478-89. [PMID:10646498]
2. Curran MP, Robinson DM. (2008)
Mosapride in gastrointestinal disorders.
Drugs, 68 (7): 981-91. [PMID:18457463]
3. Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, Müller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH et al.. (2012)
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
Aliment Pharmacol Ther, 35 (7): 745-67. [PMID:22356640]